SCHEMBL5760

SCHEMBL5760

COC=C1CCC2(CC1)CCN(c1ccc(C(C)(C)C)cc1)C2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.35
HSD11B1 P28845 3/20 0.35
KDM4E B2RXH2 1/20 0.35
HTT P42858 1/20 0.35
CYP3A4 P08684 14/20 0.35
CYP2C9 P11712 6/20 0.35
CYP1A2 P05177 6/20 0.35
USP2 O75604 6/20 0.35
HSD17B10 Q99714 6/20 0.35
HIF1A Q16665 4/20 0.35
ALOX15 P16050 2/20 0.35
MAPK1 P28482 1/20 0.35
CYP2C19 P33261 7/20 0.34
TSHR P16473 2/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
HPGD P15428 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP2D6 P10635 1/20 0.33
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5989 0.73 CYP3A4 (0.40) ALDH1A1KDM4EHTTCYP3A4CYP2C9
SCHEMBL5548 0.71 CYP3A4 (0.36) ALDH1A1HSD11B1KDM4EHTTCYP3A4
SCHEMBL4615 0.71 HSD11B1 (0.42) ALDH1A1HSD11B1KDM4EHTTCYP3A4
SCHEMBL24124025 0.70 HSD11B1 (0.41) ALDH1A1HSD11B1KDM4EHTTCYP2C9
SCHEMBL5651 0.69 LIPE (0.38) ALDH1A1HSD11B1CYP3A4CYP2C9CYP1A2
SCHEMBL5391 0.68 CYP3A4 (0.35) ALDH1A1KDM4EHTTCYP3A4CYP2C9
SCHEMBL5559 0.68 FFAR4 (0.39) ALDH1A1HSD11B1CYP3A4CYP2C9CYP1A2
SCHEMBL22680902 0.67 MAPT (0.46) ALDH1A1HSD11B1KDM4EHTTUSP2
SCHEMBL24123997 0.66 CYP2D6 (0.63) ALDH1A1HSD11B1CYP3A4CYP2C9CYP1A2
SCHEMBL4403156 0.65 HSD11B1 (0.47) ALDH1A1HSD11B1KDM4EHTTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed